Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study-Reference-Cited by-同舟云学术

Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study

Published:2020-08-01 Issue:1 Volume:19 Page:93-100
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Tomasiewicz Krzysztof¹^ORCID,Piekarska Anna²,Stempkowska-Rejek Justyna¹,Serafińska Sylwia³,Gawkowska Aleksandra³,Parczewski Miłosz⁴,Niścigorska-Olsen Jolanta⁴,Łapiński Tadeusz W.⁵,Zarębska-Michaluk Dorota⁶^ORCID,Kowalska Justyna D.⁷^ORCID,Horban Andrzej⁷^ORCID,Flisiak Robert⁵^ORCID

Affiliation:

1. Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland

2. Department of Infectious Diseases and Hepatology, Medical University of Lodz, Lodz, Poland

3. Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Wroclaw, Poland

4. Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University, Szczecin, Poland

5. Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland

6. Department of Infectious Diseases, Voivodeship Hospital and Jan Kochanowski University, Kielce, Poland

7. Department of Adults’ Infectious Diseases, Medical University of Warsaw, Warsaw, Poland

Funder

Polish Association of Epidemiologists and Infectiologists and Roche Poland

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2020.1800453

Reference27 articles.

1. The World Health Organization. Coronavirus disease. 2019 (COVID-19) situation report – 159. [cited 2020 Jun 20]. Avialable from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200627-covid-19-sitrep-159.pdf?sfvrsn=93e027f6_2

2. Covid-19: four fifths of cases are asymptomatic, China figures indicate

3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

4. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Interleukin 6 and Interleukin 8 in type 2 Diabetic patients recovered from SARS_COV_2 induced Covid 19 infection in Kirkuk City, Iraq;Research Journal of Biotechnology;2024-07-31

2. Safety and efficacy of tocilizumab in critically ill patients with COVID-19: an observational study;The Egyptian Journal of Bronchology;2023-09-01

3. Tocilizumab for the treatment of COVID-19;Expert Review of Anti-infective Therapy;2023-06-19

4. The effectiveness of Tocilizumab in severe covid 19 pneumonia among critically ill patients;Research Journal of Pharmacy and Technology;2023-02-28

5. Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection;International Journal of Molecular Sciences;2022-11-21